Cigna Corp's demonstrates a contracting trajectory supported by slightly volatile movement. It is projected to decline toward approximately 2.8 B. Net Income Applicable To Common Shares is the net income that remains after preferred dividends have been deducted, available to common shareholders. View All Fundamentals
The Net Income Applicable To Common Shares trend for Cigna Corp offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Cigna Corp is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Cigna Corp's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Cigna Corp over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Cigna Corp's Net Income Applicable To Common Shares historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cigna Corp's overall financial position and show how it may be relating to other accounts over time.
Cigna Net Income Applicable To Common Shares Regression Statistics
Arithmetic Mean
3,367,721,569
Geometric Mean
2,821,029,254
Coefficient Of Variation
62.77
Mean Deviation
1,713,888,120
Median
2,637,000,000
Standard Deviation
2,113,794,233
Sample Variance
4468126.1T
Range
7.5B
R-Value
0.62
Mean Square Error
2931299.1T
R-Squared
0.38
Significance
0.01
Slope
259,715,768
Total Sum of Squares
71490016.9T
Cigna Net Income Applicable To Common Shares History
2026
2.8 B
2025
3.9 B
2024
3.4 B
2023
5.2 B
2022
6.7 B
2021
5.4 B
2020
8.5 B
Stock Overview, Methodology & Data Sources
Cigna Corporation provides insurance and related products and services in the United States. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut. Cigna Corp operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 72226 people. Liquidity and trading activity can influence how quickly new information is reflected in Cigna Corp's price. Lower trading activity may introduce occasional variability in execution conditions. Cigna Corp has a market cap of 71.37 B, P/E of 13.93, ROE of 15.13%.
Methodology
Unless otherwise specified, financial data for Cigna Corp is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Cigna (USA Stocks:CI) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We use public filings and market reference sources with disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA) as reference inputs. Data may be normalized and can be delayed. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Cigna Corp has active sell-side coverage. Source-validated coverage currently shows 25 approved analysts, while broader market-consensus totals may differ across providers due to methodology and update timing. 12 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Citigroup, HSBC Global Research, Stifel, Wells Fargo Securities, UBS Investment Research, RBC Capital Markets, Bank of America Securities, J.P. Morgan, Jefferies, Oppenheimer & Co., among others. Updates may occur throughout the day.
Cigna Corp Correlation provides competitor comparison context for Cigna Corp. The view adds relative comparison context.
New to investing in Cigna Stock? Start with our How to Invest in Cigna Stock guide for a step-by-step overview.With Cigna Corp showing P/E 13.93 and ROE 15.13%, investors get more value when this analysis is combined with the diversification and construction tools below. Those return and profitability levels shape the investment picture - the supplemental tools help investors decide if they are sustainable. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Quarterly Earnings Growth
-0.09
Dividend Share
6.04
Earnings Share
22.18
Revenue Per Share
1 K
Quarterly Revenue Growth
0.104
Understanding Cigna Corp includes distinguishing between market value and book value, where book value reflects Cigna's accounting equity. Cigna Corp's market capitalization is 71.37 B. At P/B 1.69, Cigna Corp trades moderately above book value. Enterprise value stands at 94.2 B. Value and price for Cigna Corp are related but not identical, and they can diverge across cycles. Trading price represents the transaction level agreed by market participants.
It is useful to distinguish Cigna Corp's value from its trading price, which are computed with different methods. For Cigna Corp, key inputs include a P/E ratio of 13.93, a P/B ratio of 1.69, a profit margin of 2.17%, and ROE of 15.13%. In practice, Cigna Corp price is set by the continuous auction process on its listing exchange.